Ghana FDA asserts authority in blacklisted Bliss case
This article was originally published in Scrip
Executive Summary
The Food and Drugs Authority of Ghana has defended its action to blacklist Bliss GVS Pharma, citing a series of regulatory violations by the Indian firm, and suggested that apparent attempts to challenge its legal authority in the matter would be unsuccessful.